In HIV-1 infection elevated serum levels of interferon-α (IFN-α) and interleukin-10 (IL-10) are associated with immune hyperactivation and disease progression. Recently, coexpression of CD49b and LAG-3 was shown to identify Type 1 regulatory T (Tr1) cells, which secrete large amounts of the immunosuppressive cytokine IL-10. We analyzed the frequency of CD49b/LAG-3+ Tr1 cells in the peripheral blood of HIV-infected individuals at different stages of the disease. We found increased levels of CD49b/LAG-3+ Tr1 cells as well as IL-10 in HIV patients. With disease progression, Tr1 cells negatively correlate with frequency of plasmacytoid dendritic cells (pDCs), the main producers of IFN-α. However, elevated IL-10 levels could not be ascribed to the CD49b/LAG-3+Tr1 cell population. Moreover, we showed in vitro that IFN-α leads to an upregulation of IL-10 as well as CD49b/LAG-3+ Tr1 cell counts in healthy controls, recapitulating effects observed in vivo during HIV infection. Our results suggest that overexpression of IFN-α during HIV infection drives the generation of CD49b/LAG-3+ Tr1 cells and the immunosuppressive cytokine IL-10. Furthermore, it remains unclear whether elevated IL-10 levels are beneficial or detrimental in regard to disease progression.
Get full access to this article
View all access options for this article.
References
1.
ChevalierMF and WeissL: The split personality of regulatory T cells in HIV infection. Blood, 2013; 121(1):29–37.
2.
KanwarB, FavreD, and McCuneJM: Th17 and regulatory T cells: Implications for AIDS pathogenesis. Curr Opin HIV AIDS, 2010; 5(2):151–157.
3.
RoncaroloMG and BattagliaM: Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat Rev Immunol, 2007; 7(8):585–598.
4.
RoncaroloMG, GregoriS, LucarelliB, et al.: Clinical tolerance in allogeneic hematopoietic stem cell transplantation. Immunol Rev, 2011; 241(1):145–163.
5.
PotC, ApetohL, and KuchrooVK: Type 1 regulatory T cells (Tr1) in autoimmunity. Semin Immunol, 2011; 23(3):202–208.
6.
KohyamaM, SugaharaD, SugiyamaS, et al.: Inducible costimulator-dependent IL-10 production by regulatory T cells specific for self-antigen. Proc Natl Acad Sci USA, 2004; 101(12):4192–4197.
7.
GrouxH, O'GarraA, BiglerM, et al.: A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature, 1997; 389(6652):737–742.
8.
GaglianiN, MagnaniCF, HuberS, et al.: Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells. Nat Med, 2013; 19(6):739–746.
9.
BrockmanMA, KwonDS, TigheDP, et al.: IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells. Blood, 2009; 114(2):346–356.
10.
StylianouE, AukrustP, KvaleD, et al.: IL-10 in HIV infection: Increasing serum IL-10 levels with disease progression—down-regulatory effect of potent anti-retroviral therapy. Clin Exp Immunol, 1999; 116(1):115–120.
11.
EstesJD, GordonSN, ZengM, et al.: Early resolution of acute immune activation and induction of PD-1 in SIV-infected sooty mangabeys distinguishes nonpathogenic from pathogenic infection in rhesus macaques. J Immunol, 2008; 180(10):6798–6807.
12.
AveryPR and HooverEA: Gamma interferon/interleukin 10 balance in tissue lymphocytes correlates with down modulation of mucosal feline immunodeficiency virus infection. J Virol, 2004; 78(8):4011–4019.
13.
EjrnaesM, FilippiCM, MartinicMM, et al.: Resolution of a chronic viral infection after interleukin-10 receptor blockade. J Exp Med, 2006; 203(11):2461–2472.
14.
FiorentinoDF, ZlotnikA, VieiraP, et al.: IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol, 1991; 146(10):3444–3451.
15.
AllavenaP, PiemontiL, LongoniD, et al.: IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages. Eur J Immunol, 1998; 28(1):359–369.
16.
BuelensC, VerhasseltV, De GrooteD, et al.: Interleukin-10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin-4 and granulocyte/macrophage-colony-stimulating factor. Eur J Immunol, 1997; 27(3):756–762.
17.
de Waal MalefytR, HaanenJ, SpitsH, et al.: Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med, 1991; 174(4):915–924.
18.
KwonDS, AnginM, HongoT, et al.: CD4+ CD25+ regulatory T cells impair HIV-1-specific CD4 T cell responses by upregulating interleukin-10 production in monocytes. J Virol, 2012; 86(12):6586–6594.
19.
ClericiM, WynnTA, BerzofskyJA, et al.: Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J Clin Invest, 1994; 93(2):768–775.
20.
LehmannC, LaffertyM, Garzino-DemoA, et al.: Plasmacytoid dendritic cells accumulate and secrete interferon alpha in lymph nodes of HIV-1 patients. PLoS One, 2010; 5(6):e11110.
21.
LehmannC, JungN, FörsterK, et al.: Longitudinal analysis of distribution and function of plasmacytoid dendritic cells in peripheral blood and gut mucosa of HIV infected patients. J Infect Dis, 2014; 209(6):940–949.
22.
PestkaS, LangerJA, ZoonKC, and SamuelCE: Interferons and their actions. Annu Rev Biochem, 1987; 56:727–777.
23.
SamuelCE: Antiviral actions of interferon. Interferon-regulated cellular proteins and their surprisingly selective antiviral activities. Virology, 1991; 183(1):1–11.
24.
AudigéA, UrosevicM, SchlaepferE, et al.: Anti-HIV state but not apoptosis depends on IFN signature in CD4+ T cells. J Immunol, 2006; 177(9):6227–6237.
25.
ZellaD, RomerioF, CurreliS, et al.: IFN-alpha 2b reduces IL-2 production and IL-2 receptor function in primary CD4+ T cells. J Immunol, 2000; 164(5):2296–2302.
26.
RomerioF and ZellaD: MEK and ERK inhibitors enhance the anti-proliferative effect of interferon-alpha2b. FASEB J, 2002; 16(12):1680–1682.
27.
HazenbergMD, StuartJW, OttoSA, et al.: T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: A longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART). Blood, 2000; 95(1):249–255.
28.
RodriguezB, LedermanMM, JiangW, et al.: Interferon-alpha differentially rescues CD4 and CD8 T cells from apoptosis in HIV infection. AIDS, 2006; 20(10):1379–1389.
29.
JacquelinB, MayauV, TargatB, et al.: Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response. J Clin Invest, 2009; 119(12):3544–3555.
30.
AmanMJ, TretterT, EisenbeisI, et al.: Interferon-alpha stimulates production of interleukin-10 in activated CD4+ T cells and monocytes. Blood, 1996; 87(11):4731–4736.
31.
JinHT, JeongYH, ParkHJ, and HaSJ: Mechanism of T cell exhaustion in a chronic environment. BMB Rep, 2011; 44(4):217–231.
32.
LevingsMK, SangregorioR, GalbiatiF, et al.: IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells. J Immunol, 2001; 166(9):5530–5539.
33.
Baecher-AllanC, BrownJA, FreemanGJ, and HaflerDA: CD4+ CD25high regulatory cells in human peripheral blood. J Immunol, 2001; 167(3):1245–1253.
34.
ManchesO, MunnD, FallahiA, et al.: HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenase-dependent mechanism. J Clin Invest, 2008; 118(10):3431–3439.
35.
OstrowskiMA, GuJX, KovacsC, et al.: Quantitative and qualitative assessment of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cell immunity to gag in HIV-1-infected individuals with differential disease progression: Reciprocal interferon-gamma and interleukin-10 responses. J Infect Dis, 2001; 184(10):1268–1278.
36.
WeissL, Donkova-PetriniV, CaccavelliL, et al.: Human immunodeficiency virus-driven expansion of CD4+ CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood, 2004; 104(10):3249–3256.
37.
AnderssonJ, BoassoA, NilssonJ, et al.: The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients. J Immunol, 2005; 174(6):3143–3147.
38.
CabreraR, TuZ, XuY, et al.: An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection. Hepatology, 2004; 40(5):1062–1071.
39.
AandahlEM, MichaëlssonJ, MorettoWJ, et al.: Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J Virol, 2004; 78(5):2454–2459.
40.
LundgrenA, Suri-PayerE, EnarssonK, et al.: Helicobacter pylori-specific CD4+ CD25high regulatory T cells suppress memory T-cell responses to H. pylori in infected individuals. Infect Immun, 2003; 71(4):1755–1762.
41.
Schulze Zur WieschJ, ThomssenA, HartjenP, et al.: Comprehensive analysis of frequency and phenotype of T regulatory cells in HIV infection: CD39 expression of FoxP3+ T regulatory cells correlates with progressive disease. J Virol, 2011; 85(3):1287–1297.
42.
PresicceP, ShawJM, MillerCJ, et al.: Myeloid dendritic cells isolated from tissues of SIV-infected Rhesus macaques promote the induction of regulatory T cells. AIDS, 2012; 26(3):263–273.
43.
McGuirkP, McCannC, and MillsKH: Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: A novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J Exp Med, 2002; 195(2):221–231.
44.
XuX, SumitaK, FengC, et al.: Down-regulation of IL-12 p40 gene in Plasmodium berghei-infected mice. J Immunol, 2001; 167(1):235–241.
45.
CurreliS, RomerioF, SecchieroP, and ZellaD: IFN-alpha2b increases interleukin-10 expression in primary activated human CD8+ T cells. J Interferon Cytokine Res, 2002; 22(12):1167–1173.
46.
AkridgeRE, OyafusoLK, and ReedSG: IL-10 is induced during HIV-1 infection and is capable of decreasing viral replication in human macrophages. J Immunol, 1994; 153(12):5782–5789.
47.
Diaz-MitomaF, KumarA, KarimiS, et al.: Expression of IL-10, IL-4 and interferon-gamma in unstimulated and mitogen-stimulated peripheral blood lymphocytes from HIV-seropositive patients. Clin Exp Immunol, 1995; 102(1):31–39.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
